| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S0012162201002833 |
| P698 | PubMed publication ID | 12418611 |
| P2093 | author name string | Elizabeth Berry-Kravis | |
| P433 | issue | 11 | |
| P921 | main subject | fragile X syndrome | Q221472 |
| P304 | page(s) | 724-728 | |
| P577 | publication date | 2002-11-01 | |
| P1433 | published in | Developmental Medicine and Child Neurology | Q15716651 |
| P1476 | title | Epilepsy in fragile X syndrome. | |
| P478 | volume | 44 |
| Q40252551 | A multidisciplinary approach to the management of individuals with fragile X syndrome. |
| Q35483780 | A novel fragile X syndrome mutation reveals a conserved role for the carboxy-terminus in FMRP localization and function. |
| Q34392818 | A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel |
| Q90105841 | A single early-life seizure results in long-term behavioral changes in the adult Fmr1 knockout mouse |
| Q37013536 | A target cell-specific role for presynaptic Fmr1 in regulating glutamate release onto neocortical fast-spiking inhibitory neurons |
| Q37504141 | APP Causes Hyperexcitability in Fragile X Mice |
| Q35844502 | Absence of metabotropic glutamate receptor-mediated plasticity in the neocortex of fragile X mice. |
| Q37577454 | Activity-dependent modulation of neural circuit synaptic connectivity |
| Q24632814 | Advances in the treatment of fragile X syndrome |
| Q33901217 | Aging in fragile X syndrome. |
| Q26796317 | Altered Neuronal and Circuit Excitability in Fragile X Syndrome. |
| Q35514214 | Altered neocortical rhythmic activity states in Fmr1 KO mice are due to enhanced mGluR5 signaling and involve changes in excitatory circuitry |
| Q46084368 | Astrocytic Contributions to Synaptic and Learning Abnormalities in a Mouse Model of Fragile X Syndrome |
| Q35824354 | Autism Spectrum Disorder (ASD) and Fragile X Syndrome (FXS): Two Overlapping Disorders Reviewed through Electroencephalography-What Can be Interpreted from the Available Information? |
| Q35762766 | Autism spectrum disorder and epilepsy: Disorders with a shared biology |
| Q26853603 | Autism spectrum disorders and neuropathology of the cerebellum |
| Q34200757 | Autoimmune disease in mothers with the FMR1 premutation is associated with seizures in their children with fragile X syndrome |
| Q22252334 | Convulsing toward the pathophysiology of autism |
| Q30418164 | Deletion of Fmr1 alters function and synaptic inputs in the auditory brainstem. |
| Q42655986 | Deletion of Fmr1 results in sex-specific changes in behavior |
| Q26995242 | Dendritic spine dysgenesis in autism related disorders |
| Q30505749 | Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome |
| Q64244182 | Dysregulated Ca-Permeable AMPA Receptor Signaling in Neural Progenitors Modeling Fragile X Syndrome |
| Q30378165 | Electrocortical changes associated with minocycline treatment in fragile X syndrome. |
| Q35819392 | Emergency department and inpatient hospitalizations for young people with fragile X syndrome |
| Q31060238 | Epilepsy and Autism |
| Q37087429 | Epileptic Electroencephalography Profile Associates with Attention Problems in Children with Fragile X Syndrome: Review and Case Series. |
| Q38461909 | Evaluation of a neurotherapy program for a child with ADHD with Benign Partial Epilepsy with Rolandic Spikes (BPERS) using event-related potentials |
| Q47657806 | Fragile X Mental Retardation Protein Requirements in Activity-Dependent Critical Period Neural Circuit Refinement. |
| Q33766106 | Fragile X Syndrome: Prevalence, Treatment, and Prevention in China |
| Q34198650 | Fragile X and autism: Intertwined at the molecular level leading to targeted treatments |
| Q42226635 | Fragile X protein FMRP is required for homeostatic plasticity and regulation of synaptic strength by retinoic acid |
| Q26863615 | Fragile X syndrome as a rare disease in China - Therapeutic challenges and opportunities |
| Q28076950 | Fragile X syndrome: A review of clinical management |
| Q36498006 | Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics. |
| Q35661582 | Fragile X syndrome: the GABAergic system and circuit dysfunction |
| Q37900184 | Fragile X-associated disorders: a clinical overview. |
| Q30479991 | Fragile X: a family of disorders |
| Q35187269 | Fragile x syndrome and autism: from disease model to therapeutic targets |
| Q27339352 | Functional magnetic resonance imaging in awake transgenic fragile X rats: evidence of dysregulation in reward processing in the mesolimbic/habenular neural circuit |
| Q46092790 | Genetic Reduction of Matrix Metalloproteinase-9 Promotes Formation of Perineuronal Nets Around Parvalbumin-Expressing Interneurons and Normalizes Auditory Cortex Responses in Developing Fmr1 Knock-Out Mice. |
| Q34689960 | Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models |
| Q41849184 | Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome |
| Q36978553 | Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome |
| Q37564195 | Impaired activity-dependent neural circuit assembly and refinement in autism spectrum disorder genetic models |
| Q35543947 | Impaired inhibitory control of cortical synchronization in fragile X syndrome |
| Q33926696 | Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder. |
| Q37402548 | Investigating the role of the actin regulating complex ARP2/3 in rapid ischemic tolerance induced neuro-protection |
| Q37372251 | Issues in Clinical Epileptology: A View from the Bench. A Festschrift in Honor of Philip A. Schwartzkroin, PhD. |
| Q26866506 | Learning and behavioral deficits associated with the absence of the fragile X mental retardation protein: what a fly and mouse model can teach us. |
| Q37220443 | Limbic epileptogenesis in a mouse model of fragile X syndrome |
| Q30537599 | Lovastatin corrects excess protein synthesis and prevents epileptogenesis in a mouse model of fragile X syndrome |
| Q64443973 | Lovastatin, not simvastatin, corrects core phenotypes in the fragile X mouse model |
| Q35823293 | MeCP2+/- mouse model of RTT reproduces auditory phenotypes associated with Rett syndrome and replicate select EEG endophenotypes of autism spectrum disorder |
| Q33839140 | Melatonin as a Novel Interventional Candidate for Fragile X Syndrome with Autism Spectrum Disorder in Humans |
| Q30420595 | Modeling fragile X syndrome in the Fmr1 knockout mouse |
| Q34230612 | Modulation of the GABAergic pathway for the treatment of fragile X syndrome |
| Q90288224 | Multifaceted Changes in Synaptic Composition and Astrocytic Involvement in a Mouse Model of Fragile X Syndrome |
| Q24306675 | Multiple autism-linked genes mediate synapse elimination via proteasomal degradation of a synaptic scaffold PSD-95 |
| Q38826557 | Novel roles of amyloid-beta precursor protein metabolites in fragile X syndrome and autism. |
| Q33715073 | Open-label add-on treatment trial of minocycline in fragile X syndrome |
| Q43067748 | Origins of epilepsy in fragile X syndrome |
| Q36090455 | Pathological plasticity in fragile X syndrome |
| Q38641503 | Public Health Literature Review of Fragile X Syndrome |
| Q29568316 | Regulation of GABAA receptors by fragile X mental retardation protein |
| Q35196556 | Regulation of molecular pathways in the Fragile X Syndrome: insights into Autism Spectrum Disorders |
| Q27011565 | Repeat-mediated genetic and epigenetic changes at the FMR1 locus in the Fragile X-related disorders |
| Q35789597 | Reprogramming patient-derived cells to study the epilepsies |
| Q28593254 | Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486. |
| Q30455160 | Resilience to audiogenic seizures is associated with p-ERK1/2 dephosphorylation in the subiculum of Fmr1 knockout mice. |
| Q35093626 | Resting-state EEG oscillatory dynamics in fragile X syndrome: abnormal functional connectivity and brain network organization |
| Q30473360 | Reversal of fragile X phenotypes by manipulation of AβPP/Aβ levels in Fmr1KO mice |
| Q55490353 | Secondary medical diagnosis in fragile X syndrome with and without autism spectrum disorder. |
| Q26773167 | Single-Nucleotide Mutations in FMR1 Reveal Novel Functions and Regulatory Mechanisms of the Fragile X Syndrome Protein FMRP |
| Q30445118 | Soy-based diet exacerbates seizures in mouse models of neurological disease |
| Q38070017 | Synaptic retinoic acid signaling and homeostatic synaptic plasticity |
| Q37097136 | The cyclic AMP phenotype of fragile X and autism |
| Q38153990 | The effects of early-life seizures on hippocampal dendrite development and later-life learning and memory |
| Q37359934 | The fragile X mental retardation protein in circadian rhythmicity and memory consolidation |
| Q90696674 | The fragile X mutation impairs homeostatic plasticity in human neurons by blocking synaptic retinoic acid signaling |
| Q37589711 | The fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development. |
| Q35614072 | Therapeutic strategies in fragile X syndrome: dysregulated mGluR signaling and beyond |
| Q47660831 | Tonotopic alterations in inhibitory input to the medial nucleus of the trapezoid body in a mouse model of Fragile X syndrome. |
| Q88236229 | Translation-relevant EEG phenotypes in a mouse model of Fragile X Syndrome |
| Q93005085 | Urine microRNA Profiling Displays miR-125a Dysregulation in Children with Fragile X Syndrome |
| Q24613049 | What can we learn about autism from studying fragile X syndrome? |
| Q89977007 | mTOR-Related Cell-Clearing Systems in Epileptic Seizures, an Update |
Search more.